Trials / Completed
CompletedNCT02263469
A Study to Investigate the Safety and Efficacy of Replenine®-VF in Haemophilia B Patients Under the Age of 6 Years
An Open Multi-centre Phase III Study to Investigate the Safety and Efficacy of Replenine®-VF in Severe Haemophilia B Patients Under the Age of 6 Years
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Bio Products Laboratory · Academic / Other
- Sex
- All
- Age
- 6 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study was to assess the safety and efficacy of Replenine®-VF in children enrolled in the study, under the age of six years, with severe haemophilia B.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Replenine®-VF (High Purity Factor IX) |
Timeline
- Start date
- 2005-08-01
- Primary completion
- 2006-07-01
- First posted
- 2014-10-13
- Last updated
- 2014-10-13
Locations
4 sites across 2 countries: Poland, Ukraine
Source: ClinicalTrials.gov record NCT02263469. Inclusion in this directory is not an endorsement.